Expert Perspective: Outcomes in Fetuses and Neonates with Severe LQTS

Description

HRS member Jeremy P. Moore, MD, MS, FHRS, CCDS, CEPS-P, presents new data showing that fetuses and/or newborns with LQT3, but not those with LQT1 or LQT2, presenting with severe arrhythias are at high risk of frequent and lethal cardiac events. Genotyping is, therefore, useful for risk stratification among affected fetuses and newborns.

Summary


Availability:	On-Demand


Cost:	FREE

Credit Offered:

No Credit Offered

Recommended

EP101 - A Program for Incoming EP Fellows

No Credit

FREE

(20)

HRS 2020 Science- May

Multiple Credits

FREE

(40)

EP 101 2020: A Virtual Program for Incoming EP Fellows

No Credit

FREE

(2)

EP Fellows Curriculum: Advanced Mapping and Ablation Techniques to Treat VA From the LV Summit and Interventricular Septum

No Credit

FREE